There is currently a demand for anti-adhesive materials that are capable of preventing the formation of intra-abdominal adhesions. In this study, electrospun poly(lactide-co-glycolide) scaffolds were dip-coated in aqueous solutions of polyvinyl alcohol with concentrations of 3 wt.%, 6 wt.% and 9 wt.% to obtain a nontoxic and anti-adhesive biomedical material. The viscosities of the applied 3 wt.%, 6 wt.% and 9 wt.% polyvinyl alcohol solutions were 7.7 mPa∙s, 38.2 mPa∙s and 180.8 mPa∙s, respectively, and increased exponentially. It is shown that increasing the viscosity of the polyvinyl alcohol solution from 6 wt.% to 9 wt.% increases the thickness of the polyvinyl alcohol layer from (3.32 ± 0.97) µm to (8.09 ± 1.43) µm. No pronounced polyvinyl alcohol layer can be observed on samples dip-coated in 3 wt.% PVA solution. Increasing the viscosity of the polyvinyl alcohol solution from 3 wt.% to 9 wt.% increases the mechanical properties of the poly(lactide-co-glycolide) samples by a factor of 1.16–1.45. Cytotoxicity analysis of all samples reveals that none is toxic to 3T3-L1 fibroblast cells. A cell adhesion assay indicates that the anti-adhesion properties increase with increasing viscosity of the polyvinyl alcohol solution and the thickness of the polyvinyl alcohol layer on the poly(lactide-co-glycolide) scaffolds. Fluorescence images of the cells show that as the thickness of the polyvinyl alcohol coating increases, the number of cells decreases, and they do not cover the surface of the samples and form spherical three-dimensional agglomerates. The highest mechanical and anti-adhesion properties are obtained with the poly(lactide-co-glycolide) scaffold sample dip-coated in the 9 wt.% polyvinyl alcohol solution. This is because this sample has the thickest polyvinyl alcohol coating.

The addition of hydroxyapatite (HAP) to electrospun poly-L-lactide (PLLA) scaffolds promotes cell adhesion and differentiation but generally leads to a significant deterioration in mechanical properties due to particle agglomeration. Moreover, the encapsulation of HAP particles within a polymer layer makes them inaccessible to body fluids and cells, thereby limiting the bioactivity of the resulting composite scaffold. In this work, HAP microparticles with median size of 26.3 µm were used to obtain exposed HAP particles on the surface of electrospun PLLA fibers. SEM images and EDX maps revealed that individual particles, particularly the larger ones, were exposed from the polymer scaffold surface. The addition of HAP particles significantly altered the scaffold morphology and structure, increasing the fiber diameter and surface roughness by 2.8–4.1-fold, promoting the formation of fused fiber junctions, and inducing the appearance of semicrystalline PLLA domains. These structural changes significantly improved the mechanical properties of the scaffolds. Specifically, the tensile strength and Young’s modulus of the prepared scaffolds are increased by 2.3–3.8-fold following HAP incorporation. Compared with neat PLLA scaffolds, HAP-containing scaffolds exhibited 1.2–1.4-fold higher osteocalcin and osteopontin expression by human adipose-derived mesenchymal stromal cells (hADSCs). Compared to tissue culture plastic, the expressions of osteocalcin and osteopontin on the composite scaffolds were 7.1–7.9-fold and 2.8–3.0-fold higher, respectively.